subject area of
- A Systematic Review and Meta-Analysis of the Diagnostic Performance of BRAF V600E Immunohistochemistry in Thyroid Histopathology Journal Articles
- Activated MKK3/MYC crosstalk impairs dabrafenib response in BRAFV600E colorectal cancer leading to resistance Journal Articles
- Adjuvant Chemotherapy With or Without Biologics Including Antiangiogenics and Monoclonal Antibodies Targeting EGFR and EpCAM in Colorectal Cancer: A Systematic Review and Meta-analysis Journal Articles
- Association BetweenNRASandBRAFMutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma Journal Articles
- BRAF status modulates Interelukin-8 expression through a CHOP-dependent mechanism in colorectal cancer Journal Articles
- Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas Journal Articles
- Dual NRASQ61R and BRAFV600E mutation-specific immunohistochemistry completes molecular screening in melanoma samples in a routine practice Journal Articles
- Fetal Autopsy Findings of Cardiofaciocutaneous Syndrome with a Unique BRAF Mutation Journal Articles
- Follicular Variant Papillary Thyroid Carcinoma Arising in Struma Ovarii Journal Articles
- Identification of amidoheteroaryls as potent inhibitors of mutant (V600E) B-Raf kinase with in vivo activity Journal Articles
- KEYNOTE-022: Pembrolizumab with trametinib in patients with BRAF wild-type melanoma or advanced solid tumours irrespective of BRAF mutation Journal Articles
- Langerhans Cell Histiocytosis Associated With Renal Cell Carcinoma Is a Neoplastic Process Conferences
- Melanoma brain metastasis: overview of current management and emerging targeted therapies. Journal Articles
- Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma Journal Articles
- Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance Journal Articles
- Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study Journal Articles
- Promising response of dabrafenib, trametinib, and osimertinib combination therapy for concomitant BRAF and EGFR-TKI resistance mutations Journal Articles
- Real-World Evidence of Systemic Therapy Sequencing on Overall Survival for Patients with Metastatic BRAF-Mutated Cutaneous Melanoma Journal Articles
- Signature Celebration of Gastroenterology , Colorectal Cancer Journal Articles
- Systemic Therapy for Previously Untreated Advanced BRAF -Mutated Melanoma: Navigating a Shifting Landscape Journal Articles
- Systemic Therapy for Previously Untreated Advanced BRAF-Mutated Melanoma Journal Articles
- Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas Journal Articles
- Update on Immunotherapeutics in the Management of Metastatic Melanoma. Journal Articles
- Vemurafenib-induced radiation recall dermatitis: case report and review of the literature. - PubMed - NCBI Other